Patent №
US 6,399,760
Granted
2002-06-04
Filed 1996
Owner
MILLENNIUM PHARMACEUTICALS, INC.
Lab
—
AI components
1
evo
Assignment
Recorded
Dataset
AIPD
2023_r1 edition
Application
08697766
The present invention, which is based on the discovery of novel genes encoding rp polypeptides, features therapeutics, diagnostics and screening assays.
AI classification
Evolutionary computation0.53
Natural language0.01
Vision0.01
Speech0.00
Planning0.00
Machine learning0.00
Knowledge representation0.00
AI hardware0.00
Ownership
MILLENNIUM PHARMACEUTICALS, INC.
assignment · 82500802
Assignors
GIMENO, CARLOS J., KLEYN, PATRICK W., MOORE, KAREN J.
On an employer assignment, the assignors are typically the inventors.
From the same owner
SYSTEMS AND METHODS FOR FILLING CONTAINERSUS 11,498,708 · 2022BIOMARKERS OF RESPONSE TO NAE INHIBITORSUS 10,953,013 · 2021BIOMARKERS AND METHODS TO PREDICT RESPONSE TO INHIBITORS AND USES THEREOFUS 10,662,477 · 2020METHODS FOR THE IDENTIFICATION, ASSESSMENT, AND TREATMENT OF PATIENTS WITH CANCER THERAPYUS 9,963,747 · 2018BIOMARKERS OF RESPONSE TO NAE INHIBITORSUS 9,827,246 · 2017METHODS FOR THE IDENTIFICATION, ASSESSMENT, AND TREATMENT OF PATIENTS WITH CANCER THERAPYUS 8,278,038 · 2012COMPOUNDS USEFUL AS ANTAGONISTS OF CCR2US 8,067,457 · 2011NOVEL COMPOSITIONS AND METHODS FOR THE IDENTIFICATION, ASSESSMENT, PREVENTION AND THERAPY OF OVARIAN CANCERUS 7,470,509 · 2008